Evidence map›Paper›PMID 30765195›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2019

Clinical and cortical decline in the aphasic variant of Alzheimer's disease.

Emily Joy Rogalski, Jaiashre Sridhar, Adam Martersteck, Benjamin Rader, Derin Cobia, Anupa K Arora, Angela J Fought, Eileen H Bigio, Sandra Weintraub, Marek-Marsel Mesulam and 1 more

Open access · greenAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Communication Bridge-2 randomized controlled trial: Recruitment and baseline features.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Trial
  3. Article
  4. Atypical Presentations of Alzheimer Disease.Continuum (Minneapolis, Minn.) · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Relationships among tau burden, atrophy, age, and naming in the aphasic variant of Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021
    Article
  12. Functional decline in the aphasic variant of Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Emily Joy RogalskiCognitive Neurology and Alzheimer's Disease Center, Northwestern University (NU) Feinberg School of Medicine, Chicago, IL, USA; NU Feinberg School of Medicine, Department of Psychiatry and Behavioral Sciences, Chicago, IL, USA. Electronic address: erogalski@gmail.com.
Jaiashre SridharCognitive Neurology and Alzheimer's Disease Center, Northwestern University (NU) Feinberg School of Medicine, Chicago, IL, USA.
Adam MartersteckCognitive Neurology and Alzheimer's Disease Center, Northwestern University (NU) Feinberg School of Medicine, Chicago, IL, USA.
Benjamin RaderCognitive Neurology and Alzheimer's Disease Center, Northwestern University (NU) Feinberg School of Medicine, Chicago, IL, USA.
Derin CobiaDepartment of Psychology, Brigham Young University, Provo, UT, USA.
Anupa K AroraAvid Radiopharmaceuticals Inc, Philadelphia, PA, USA.
Angela J FoughtNU Feinberg School of Medicine, Department of Preventive Medicine, Chicago, IL, USA.
Eileen H BigioNU Feinberg School of Medicine, Department of Pathology, Chicago, IL, USA.
Sandra WeintraubCognitive Neurology and Alzheimer's Disease Center, Northwestern University (NU) Feinberg School of Medicine, Chicago, IL, USA; NU Feinberg School of Medicine, Department of Psychiatry and Behavioral Sciences, Chicago, IL, USA.
Marek-Marsel MesulamCognitive Neurology and Alzheimer's Disease Center, Northwestern University (NU) Feinberg School of Medicine, Chicago, IL, USA; NU Feinberg School of Medicine, Department of Neurology, Chicago, IL, USA.
Alfred RademakerNU Feinberg School of Medicine, Department of Preventive Medicine, Chicago, IL, USA.
Northwestern University · USBrigham Young University · US

Funding

Neuropathology CoreP30AG013854 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BIGIO, EILEEN H. · 1996 to 2020
$28.9M
Language in Primary Progressive AphasiaR01DC008552 · NIDCD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MESULAM, MAREK-MARSEL M · 2007 to 2021
$8.5M
Determinants of neurodegenerative decline in the aphasic variant of Alzheimer's diseaseR01AG056258 · NIA · UNIVERSITY OF CHICAGO · PI ROGALSKI, EMILY J · 2017 to 2022
$4.1M
Determinants of Neurodegenerative Decline in Primary Progressive AphasiaR01NS075075 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ROGALSKI, EMILY J · 2012 to 2016
$1.7M
NIA NIH HHS P30 AG013854NIA NIH HHS R01 AG056258NIDCD NIH HHS R01 DC008552NINDS NIH HHS R01 NS075075
6 · The paper itself

Abstract

introductionPrimary progressive aphasia (PPA) displays variable progression trajectories that require further elucidation.

methodsLongitudinal quantitation of atrophy and language over 12 months was completed for PPA patients with and without positive amyloid PET (PPA

resultsOver 12 months, both PPA groups showed significantly greater cortical atrophy rates in the left versus right hemisphere, with a more widespread pattern in PPA DISCUSSION: Preferential language network neurodegeneration is present in PPA irrespective of amyloid status. Clinical and anatomical progression appears to differ for PPA due to Alzheimer's disease versus non-Alzheimer's disease neuropathology, a distinction that may help to inform prognosis and the design of intervention trials.

Indexed as

Aphasia, Primary ProgressiveAlzheimer DiseaseAmyloid beta-PeptidesAtrophyBiomarkersBrainDisease ProgressionFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMaleMiddle AgedNeuropsychological TestsPositron-Emission TomographyAmyloid beta-PeptidesBiomarkersAmyloid PETBiomarkerFreeSurferFrontotemporal dementiaFrontotemporal lobar degenerationNeuropsychologyPrimary progressive aphasiaProgressionVolumetric MRI

Identifiers

PMID30765195
PMCPMC6461481
OpenAlexW2912390149

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.